Belite Bio BLTE
NASDAQ BLTE
$155.94 -0.58 (-0.37%)
At close: Nov 11, 2026 · 4:00 PM EST

Belite Bio (BLTE) Depreciation & Amortization (CF) (2024 - 2025)

Updated

Belite Bio's Depreciation & Amortization (CF) came in at $45,000 for Q4 2025, up 4.7% from $43,000 a year earlier.

Analysis

Belite Bio (BLTE) Depreciation & Amortization (CF) (2024 - 2025) Analysis & Trends

For FY2025, Belite Bio's Depreciation & Amortization (CF) was $464,000, up 3.3% from FY2024.

  • Depreciation & Amortization (CF) has increased in each of the last five years, with a five-year compound annual growth rate of 93.7% (FY2020 to FY2025).
  • Going back by year, Depreciation & Amortization (CF) was $449,000 in FY2024 (+12.5%), $399,000 in FY2023 (+101.5%), $198,000 in FY2022 (+560.0%) and $30,000 in FY2021 (+76.5%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.12 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 192.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.61 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 132.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.58 Bn
10 Belite Bio 6.16 Bn 6.16 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 45,000.00
Dec 31, 2024 43,000.00
API Access

Belite Bio Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=BLTE&period=max&api_key=YOUR_API_KEY